Janus Henderson Group
CTIC

Janus Henderson Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Janus Henderson Group’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-44,356
Closed -$187K – 2756
2023
Q1 		$187K Buy
44,356
+22,079
+99% +$92.8K ﹤0.01% 2512
2022
Q4 		$134K Buy
+22,277
New +$134K ﹤0.01% 2282